Cargando…
Diazoxide-Induced Hypertrichosis in a Neonate With Transient Hyperinsulinism
Diazoxide is one of the FDA-approved pharmacologic treatments for hyperinsulinemic hypoglycemia, however, its adverse effects in infants are not well described. We reported a 37-week-old boy with the diagnosis of hypoglycemia. We started a dextrose infusion, but we used oral diazoxide, due to hypogl...
Autores principales: | Boskabadi, Seyyed Javad, Ramezaninejad, Sima, Sohrab, Masoumeh, Farhadi, Roya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885027/ https://www.ncbi.nlm.nih.gov/pubmed/36726424 http://dx.doi.org/10.1177/11795476231151330 |
Ejemplares similares
-
Neonatal Hypo-Ketotic Hypoglycemia Secondary to Transient Hyperinsulinism: Diazoxide Responsiveness and Experience With Fasting Test After Treatment Withdrawal
por: Martín, Nerea Itza, et al.
Publicado: (2021) -
Partial diazoxide responsiveness in a neonate with hyperinsulinism due to homozygous ABCC8 mutation
por: Kiff, Sarah, et al.
Publicado: (2019) -
A novel mutation of ABCC8 gene in a patient with diazoxide-unresponsive congenital hyperinsulinism
por: Park, Ji Sook, et al.
Publicado: (2016) -
Congenital hyperinsulinism: clinical and molecular characterisation of compound heterozygous ABCC8 mutation responsive to Diazoxide therapy
por: Arya, Ved Bhushan, et al.
Publicado: (2014) -
Suicide due to fear of COVID-19, in the last month of pregnancy, leads to neonatal seizure: A case report
por: Boskabadi, Javad, et al.
Publicado: (2021)